newsfilter
← Latest News
GlobeNewswire·

Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights

  • Akebia Therapeutics, Inc. plans to release financial results for the second quarter ended June 30, 2026, on Wednesday, August 5, 2026, following market close.
  • A conference call to discuss results & business highlights will occur on August 5, 2026, at 4:30 p.m. EDT.
  • Participants can join the call by dialing (646) 307-1963 or (800) 715-9871 using passcode 4727037.
  • A live webcast & online archive will be available via the Investors section of Akebia's website at ir.akebia.com.
  • Akebia Therapeutics is a biopharmaceutical company founded in 2007, headquartered in Cambridge, Massachusetts, focused on kidney disease treatments.